IP Library › Granted Patent US 12,367,513
Granted Patent B2
US 12,367,513 · App. 18/053,273 · Granted Jul 22, 2025

Activation of bioluminescence by structural complementation

Inventors: Andrew S. Dixon (Verona, WI); Lance Encell (Fitchburg, WI); Mary Hall (Waunakee, WI); Keith Wood (Mt. Horeb, WI); Monika Wood (Mt. Horeb, WI); Marie Schwinn (Madison, WI); Brock F. Binkowski (Sauk City, WI); Hicham Zegzouti (Madison, WI); Nidhi Nath (Madison, WI); Subhanjan Mondal (Middleton, WI); Said Goueli (Fitchburg, WI); Poncho Meisenheimer (San Luis Obispo, CA); Thomas Kirkland (Atascadero, CA); James Unch (Arroyo Grande, CA); Dileep K. Pulukkunat (Middleton, WI); Matthew Robers (Madison, WI); Melanie Dart (Madison, WI); Thomas Machleidt (Madison, WI)
Assignee: Promega Corporation
G06Q30/0283G06Q30/0631H04W4/02H04W4/35H04W4/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,367,513
App. No.
18/053,273
Granted
Jul 22, 2025
Kind
B2
Abstract

Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.

Claims (17)

1. A system comprising:

(a) a polypeptide comprising an amino acid sequence having less than 100% and greater than 40% sequence identity with SEQ ID NO: 440;

(b) a peptide comprising an amino acid sequence having less than 100% and greater than 40% sequence identity with SEQ ID NO: 2;

(c) a bioluminescent substrate having an emission spectrum; and

(d) a fluorescent dye or protein having an excitation spectrum.

2. The system of claim 1 , wherein the fluorescent dye or protein is linked to the peptide.

3. The system of claim 1 , wherein the fluorescent dye or protein is linked to the polypeptide.

4. The system of claim 1 , wherein a first fusion protein comprises the peptide and a first interaction element, wherein a second fusion protein comprises the polypeptide and a second interaction element, wherein the first and second interaction elements are configured to form and interaction complex, and wherein formation of the interaction complex facilitates formation of the bioluminescent complex.

5. The system of claim 1 , wherein the peptide comprises an amino acid sequence with at least 70% sequence identity to SEQ ID NO: 2.

6. The system of claim 1 , wherein the peptide comprises an amino acid sequence is selected from the peptide sequences of SEQ ID NOS: 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 380, 382, 384, 386, 388, 390, 392, 394, 396, 398, 400, 402, 404, 406, 408, 410, 412, 414, 416, 418, 420, 422, 424, 426, 428, 430, 432, 434, 436, 438, 2163, 2165, 2167, 2169, 2171, 2173, 2175, 2177, 2179, 2181, 2183, 2185, 2187, 2189, 2191, 2193, 2195, 2197, 2199, 2201, 2203, 2205, 2207, 2209, 2211, 2213, 2215, 2217, 2219, 2221, 2223, 2225, 2227, 2229, 2231, 2233, 2235, 2237, 2239, 2241, 2243, 2245, 2247, 2249, 2251, 2253, 2255, 2257, 2259, 2261, 2263, 2265, 2267, 2269, 2271, 2273, 2275, 2277, 2279, 2281, 2283, 2285, 2287, 2289, 2291, 2293, 2295, 2297, 2299, 2301, 2303, 2305, 2307, 2309, 2311, 2313, 2315, 2317, 2319, 2321, 2323, 2325, 2327, 2329, 2331, 2333, 2335, 2337, 2339, 2341, 2343, 2345, 2347, 2349, 2351, 2353, 2355, 2357, 2359, 2361, 2363, and 2365.

7. The system of claim 6 , wherein the peptide comprises an amino acid sequence of SEQ ID NO: 390.

8. The system of claim 6 , wherein the peptide comprises an amino acid sequence of SEQ ID NO: 2271.

9. The system of claim 1 , wherein the polypeptide comprises an amino acid sequence with at least 70% sequence identity to SEQ ID NO: 440.

10. The system of claim 1 , wherein the polypeptide comprises an amino acid sequence selected from the polypeptide sequences of SEQ ID NOS: 442, 444, 446, 448, 450, 452, 454, 456, 458, 460, 462, 464, 466, 468, 470, 472, 474, 476, 478, 480, 482, 484, 486, 488, 490, 492, 494, 496, 498, 500, 502, 504, 506, 508, 510, 512, 514, 516, 518, 520, 522, 524, 526, 528, 530, 532, 534, 536, 538, 540, 542, 544, 546, 548, 550, 552, 554, 556, 558, 560, 562, 564, 566, 568, 570, 572, 574, 576, 578, 580, 582, 584, 586, 588, 590, 592, 594, 596, 598, 600, 602, 604, 606, 608, 610, 612, 614, 616, 618, 620, 622, 624, 626, 628, 630, 632, 634, 636, 638, 640, 642, 644, 646, 648, 650, 652, 654, 656, 658, 660, 662, 664, 666, 668, 670, 672, 674, 676, 678, 680, 682, 684, 686, 688, 690, 692, 694, 696, 698, 700, 702, 704, 706, 708, 710, 712, 714, 716, 718, 720, 722, 724, 726, 728, 730, 732, 734, 736, 738, 740, 742, 744, 746, 748, 750, 752, 754, 756, 758, 760, 762, 764, 766, 768, 770, 772, 774, 776, 778, 780, 782, 784, 786, 788, 790, 792, 794, 796, 798, 800, 802, 804, 806, 808, 810, 812, 814, 816, 818, 820, 822, 824, 826, 828, 830, 832, 834, 836, 838, 840, 842, 844, 846, 848, 850, 852, 854, 856, 858, 860, 862, 864, 866, 868, 870, 872, 874, 876, 878, 880, 882, 884, 886, 888, 890, 892, 894, 896, 898, 900, 902, 904, 906, 908, 910, 912, 914, 916, 918, 920, 922, 924, 926, 928, 930, 932, 934, 936, 938, 940, 942, 944, 946, 948, 950, 952, 954, 956, 958, 960, 962, 964, 966, 968, 970, 972, 974, 976, 978, 980, 982, 984, 986, 988, 990, 992, 994, 996, 998, 1000, 1002, 1004, 1006, 1008, 1010, 1012, 1014, 1016, 1018, 1020, 1022, 1024, 1026, 1028, 1030, 1032, 1034, 1036, 1038, 1040, 1042, 1044, 1046, 1048, 1050, 1052, 1054, 1056, 1058, 1060, 1062, 1064, 1066, 1068, 1070, 1072, 1074, 1076, 1078, 1080, 1082, 1084, 1086, 1088, 1090, 1092, 1094, 1096, 1098, 1100, 1102, 1104, 1106, 1108, 1110, 1112, 1114, 1116, 1118, 1120, 1122, 1124, 1126, 1128, 1130, 1132, 1134, 1136, 1138, 1140, 1142, 1144, 1146, 1148, 1150, 1152, 1154, 1156, 1158, 1160, 1162, 1164, 1166, 1168, 1170, 1172, 1174, 1176, 1178, 1180, 1182, 1184, 1186, 1188, 1190, 1192, 1194, 1196, 1198, 1200, 1202, 1204, 1206, 1208, 1210, 1212, 1214, 1216, 1218, 1220, 1222, 1224, 1226, 1228, 1230, 1232, 1234, 1236, 1238, 1240, 1242, 1244, 1246, 1248, 1250, 1252, 1254, 1256, 1258, 1260, 1262, 1264, 1266, 1268, 1270, 1272, 1274, 1276, 1278, 1280, 1282, 1284, 1286, 1288, 1290, 1292, 1294, 1296, 1298, 1300, 1302, 1304, 1306, 1308, 1310, 1312, 1314, 1316, 1318, 1320, 1322, 1324, 1326, 1328, 1330, 1332, 1334, 1336, 1338, 1340, 1342, 1344, 1346, 1348, 1350, 1352, 1354, 1356, 1358, 1360, 1362, 1364, 1366, 1368, 1370, 1372, 1374, 1376, 1378, 1380, 1382, 1384, 1386, 1388, 1390, 1392, 1394, 1396, 1398, 1400, 1402, 1404, 1406, 1408, 1410, 1412, 1414, 1416, 1418, 1420, 1422, 1424, 1426, 1428, 1430, 1432, 1434, 1436, 1438, 1440, 1442, 1444, 1446, 1448, 1450, 1452, 1454, 1456, 1458, 1460, 1462, 1464, 1466, 1468, 1470, 1472, 1474, 1476, 1478, 1480, 1482, 1484, 1486, 1488, 1490, 1492, 1494, 1496, 1498, 1500, 1502, 1504, 1506, 1508, 1510, 1512, 1514, 1516, 1518, 1520, 1522, 1524, 1526, 1528, 1530, 1532, 1534, 1536, 1538, 1540, 1542, 1544, 1546, 1548, 1550, 1552, 1554, 1556, 1558, 1560, 1562, 1564, 1566, 1568, 1570, 1572, 1574, 1576, 1578, 1580, 1582, 1584, 1586, 1588, 1590, 1592, 1594, 1596, 1598, 1600, 1602, 1604, 1606, 1608, 1610, 1612, 1614, 1616, 1618, 1620, 1622, 1624, 1626, 1628, 1630, 1632, 1634, 1636, 1638, 1640, 1642, 1644, 1646, 1648, 1650, 1652, 1654, 1656, 1658, 1660, 1662, 1664, 1666, 1668, 1670, 1672, 1674, 1676, 1678, 1680, 1682, 1684, 1686, 1688, 1690, 1692, 1694, 1696, 1698, 1700, 1702, 1704, 1706, 1708, 1710, 1712, 1714, 1716, 1718, 1720, 1722, 1724, 1726, 1728, 1730, 1732, 1734, 1736, 1738, 1740, 1742, 1744, 1746, 1748, 1750, 1752, 1754, 1756, 1758, 1760, 1762, 1764, 1766, 1768, 1770, 1772, 1774, 1776, 1778, 1780, 1782, 1784, 1786, 1788, 1790, 1792, 1794, 1796, 1798, 1800, 1802, 1804, 1806, 1808, 1810, 1812, 1814, 1816, 1818, 1820, 1822, 1824, 1826, 1828, 1830, 1832, 1834, 1836, 1838, 1840, 1842, 1844, 1846, 1848, 1850, 1852, 1854, 1856, 1858, 1860, 1862, 1864, 1866, 1868, 1870, 1872, 1874, 1876, 1878, 1880, 1882, 1884, 1886, 1888, 1890, 1892, 1894, 1896, 1898, 1900, 1902, 1904, 1906, 1908, 1910, 1912, 1914, 1916, 1918, 1920, 1922, 1924, 1926, 1928, 1930, 1932, 1934, 1936, 1938, 1940, 1942, 1944, 1946, 1948, 1950, 1952, 1954, 1956, 1958, 1960, 1962, 1964, 1966, 1968, 1970, 1972, 1974, 1976, 1978, 1980, 1982, 1984, 1986, 1988, 1990, 1992, 1994, 1996, 1998, 2000, 2002, 2004, 2006, 2008, 2010, 2012, 2014, 2016, 2018, 2020, 2022, 2024, 2026, 2028, 2030, 2032, 2034, 2036, 2038, 2040, 2042, 2044, 2046, 2048, 2050, 2052, 2054, 2056, 2058, 2060, 2062, 2064, 2066, 2068, 2070, 2072, 2074, 2076, 2078, 2080, 2082, 2084, 2086, 2088, 2090, 2092, 2094, 2096, 2098, 2100, 2102, 2104, 2106, 2108, 2110, 2112, 2114, 2116, 2118, 2120, 2122, 2124, 2126, 2128, 2130, 2132, 2134, 2136, 2138, 2140, 2142, 2144, 2146, 2148, 2150, 2152, 2154, and 2156.

11. The system of claim 1 , wherein the peptide comprises an amino acid sequence with at least 70% sequence identity to SEQ ID NO: 2, and wherein the polypeptide comprises an amino acid sequence with at least 80% sequence identity to SEQ ID NO: 440.

12. The system of claim 11 , wherein the peptide comprises an amino acid sequence with at least 80% sequence identity to SEQ ID NO: 2, and wherein the polypeptide comprises an amino acid sequence with at least 80% sequence identity to SEQ ID NO: 440.

13. The system of claim 12 , wherein the peptide comprises an amino acid sequence with at least 90% sequence identity to SEQ ID NO: 2, and wherein the polypeptide comprises an amino acid sequence with at least 80% sequence identity to SEQ ID NO: 440.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2023
From: DIXON, ANDREW S.; ENCELL, LANCE P; HALL, MARY; WOOD, KEITH; WOOD, MONIKA; SCHWINN, MARIE; BINKOWSKI, BROCK F; ZEGZOUTI, HICHAM; NATH, NIDHI; MONDAL, SUBHANJAN; GOUELI, SAID; MEISENHEIMER, PONCHO; KIRKLAND, THOMAS; UNCH, JAMES; PULUKKUNAT, DILEEP K; ROBERS, MATTHEW; DART, MELANIE; MACHLEIDT, THOMAS
To: PROMEGA CORPORATION
Reel/Frame 063021/0626 →
Continuity (8)
Continuation 16851841 · Apr 17, 2020
Continuation 16035117 · Jul 13, 2018
Continuation 16023972 · Jun 29, 2018
Continuation 15717534 · Sep 27, 2017
Continuation 15073249 · Mar 17, 2016
Continuation 14209610 · Mar 13, 2014
Provisional Application 61791549 · Mar 15, 2013
Related Publication 20230342826A1 · Oct 26, 2023
References Cited (69)
US 4444879A · Foster et al. · 1984 [cited by applicant]
US 6242345B1 · Levy · 2001 [cited by applicant]
US 6270964B1 · Michnick et al. · 2001 [cited by applicant]
US 7314729B2 · Goueli et al. · 2008 [cited by applicant]
US 7601517B2 · Gambhir et al. · 2009 [cited by applicant]
US 8057824B2 · Roorda et al. · 2011 [cited by applicant]
US 8241860B2 · Ghosh et al. · 2012 [cited by applicant]
US 8557970B2 · Encell et al. · 2013 [cited by applicant]
US 8669103B2 · Binkowski et al. · 2014 [cited by applicant]
US 8809529B2 · Klaubert et al. · 2014 [cited by applicant]
US 9797889B2 · Dixon · 2017 [cited by examiner]
US 9797890B2 · Dixon · 2017 [cited by examiner]
US 9869670B2 · Dixon · 2018 [cited by examiner]
US 9969991B2 · Dixon et al. · 2018 [cited by applicant]
US 10107800B2 · Dixon · 2018 [cited by examiner]
US 10184936B2 · Dixon · 2019 [cited by examiner]
US 10288605B2 · Dixon · 2019 [cited by examiner]
US 10648971B2 · Dixon · 2020 [cited by examiner]
US 11493504B2 · Dixon · 2022 [cited by examiner]
US 20040115814A1 · DuBridge · 2004 [cited by applicant]
US 20070061916A1 · Kovalic et al. · 2007 [cited by applicant]
US 20080009444A1 · Nash et al. · 2008 [cited by applicant]
US 20090075313A1 · Massoud et al. · 2009 [cited by applicant]
US 20090149338A1 · Hughes et al. · 2009 [cited by applicant]
US 20100272675A1 · Leamon et al. · 2010 [cited by applicant]
US 20120034672A1 · Kim et al. · 2012 [cited by applicant]
US 20120035070A1 · Inouye et al. · 2012 [cited by applicant]
US 20120174242A1 · Binkowski et al. · 2012 [cited by applicant]
US 20140348747A1 · Dixon et al. · 2014 [cited by applicant]
US 20140363375A1 · Dixon et al. · 2014 [cited by applicant]
US 20150125438A1 · Kim et al. · 2015 [cited by applicant]
US 20160282340A1 · Dixon et al. · 2016 [cited by applicant]
US 20180313825A1 · Dixon et al. · 2018 [cited by applicant]
CN 102459579A · 2012 [cited by applicant]
EP 1156103 · 2001 [cited by applicant]
JP 2002320482 · 2002 [cited by applicant]
WO WO199306868 · 1993 [cited by applicant]
WO WO199408629 · 1994 [cited by applicant]
WO WO199409056 · 1994 [cited by applicant]
WO WO199626754 · 1996 [cited by applicant]
WO WO199834120 · 1998 [cited by applicant]
WO WO2007041251 · 2007 [cited by applicant]
WO WO2007132461 · 2007 [cited by applicant]
WO WO2010127368 · 2010 [cited by applicant]
WO 2011119484A1 · 2011 [cited by applicant]
WO WO2012061529 · 2012 [cited by applicant]
WO WO2012061530 · 2012 [cited by applicant]
WO WO2014093677 · 2014 [cited by applicant]
WO WO2014151736 · 2014 [cited by applicant]
Golla et al, A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists, J Biomol Screen, 2002, 7(6):515-25. [cited by applicant]
Berman et al., The Protein Data Bank, Nucleic Acids Res., 2000, 28:235-242. [cited by applicant]
Hall et al., Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate, ACS Chem Biol, 2012, 7:1848-1857. [cited by applicant]
Inouye et al., Secretional luciferase of the luminous shrimp Oplophorus gracilirostris: cDNA cloning of a novel imidazopyrazinone luciferase(1), FEBS Lett. Sep. 8, 2000;481(1):19-25. [cited by applicant]
Kerppola, Complementary methods for studies of protein interactions in living cells, Nat Methods, 2006, 3:969-971. [cited by applicant]
Komiya et al., Homogeneous sandwich immunoassay based on the enzymatic complementation induced by single-chain Fv fragments, Anal Biochem, 2004, 327(2):241-6. [cited by applicant]
Lim et al., Noncompetitive detection of low molecular weight peptides by open sandwich immunoassay, Anal Chem., 2007, 79(16):6193-200. [cited by applicant]
Mie et al. Development of a homogeneous immunoassay system using protein A fusion fragmented Renilla luciferase, The Analyst, 2012, 137(5):1085-9. [cited by applicant]
Shirasu et al., Noncompetitive immunodetection of benzaldehyde by open sandwich ELISA, Anal Sci., 2009, 25(9):1095-100. [cited by applicant]
Stains et al., A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly, ACS Chem Biol., 2010, 5(10):943-52. [cited by applicant]
Tascilar et al., Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Annals of Oncology 1999;10(Suppl. 4):S107-S110. [cited by applicant]
The Uniprot Consortium, “Reorganizing the protein space at the Universal Protein Resource (UniProt)”, Nucleic Acids Res., 2012, 40: D71-D75. [cited by applicant]
Tockman et al., Considerations in bringing a cancer biomarker to clinical application. Cancer Res. May 1, 1992;52(9 Suppl):2711s-2718s. [cited by applicant]
Tomalia et al. in Angew. Chem. Int. Ed. Engl. 29:138-175 (1990). [cited by applicant]
Ueda et al., An optimized homogeneous noncompetitive immunoassay based on the antigen-driven enzymatic complementation, J Immunol Methods, 2003, 279(1-2):209-18. [cited by applicant]
Ueda et al., Open sandwich ELISA: a novel immunoassay based on the interchain interaction of antibody variable region, Nat Biotechnol., 1996, 14(13):1714-8. [cited by applicant]
Yang et al., Homogeneous enzyme immunoassay modified for application to luminescence-based biosensors, Anal Biochem, 2005, 336(1):102-7. [cited by applicant]
International Search Report and Written Opinion for PCT/US2014/026354, mailed Jul. 31, 2014, 15 pages. [cited by applicant]
Supplementary European Search Report for EP14769752, mailed Jun. 24, 2016, 10 pages. [cited by applicant]
Alignment between SEQ ID No. 440 of U.S. Appl. No. 14/209,610 and SEQ ID No. 89 of World Patent Application 2012/061529, May 10, 2012, 2 Pages. [cited by applicant]